MARKET IS CLOSED
Loading latest tickers...
Market Indices
S&P 500
$7,773.95
+0.66%
NASDAQ 100
$31,076.44
+0.87%
DOW JONES
$51,268.00
+0.18%
NASDAQ Composite
$27,477.31
+1.05%
RUSSELL 2000
$2,833.80
+0.66%
CBOE VIX
$15.52
+1.37%
Sector Heatmap
Technology+0.53%
Financials+0.24%
Healthcare-0.17%
Consumer Cycl+1.20%
Consumer Staples+0.90%
Energy+0.47%
Industrials+0.87%
Materials+0.46%
Real Estate+1.06%
Utilities+2.98%
Comm Services+0.04%
LUCD — Lucid Diagnostics Inc. Common Stock
NasdaqLucid Diagnostics Inc. Common Stock
$0.60
+0.01(+1.13%)
- O
- 0.60
- H
- 0.61
- L
- 0.58
- V
- 1.45M
⏱️ End-of-day dataAs of Oct 6, 2026
Chart
About LUCD
Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard.
IndustrySURGICAL & MEDICAL INSTRUMENTS & APPARATUS
SectorNot available
IPO DateOct 14, 2021
Employees82
Stock ExchangeNasdaq
Ticker SymbolLUCD
Websitehttps://www.luciddx.com
Key Financial Statistics
| Market Cap | $119.78M |
| P/E Ratio | N/A |
| Dividend Yield | None |
| EPS | N/A |
| Beta | N/A |
| 52-Week Range | $0.50 - $1.63 |
| 52-Week Avg Volume | 1.16M |
| VWAP | $0.60 |
| Transactions | 4,663 |
| Total Recorded Bars | 1,249 days |